Approval · Notice of Compliance 5225 · 1995
PRAVACHOL: Notice of Compliance 5225
Issued March 30, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5225
- Date
- March 30, 1995
- Company
- Squibb Canada Inc., Division Of Bristol-Myers Squibb Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revised product monograph
- Therapeutic class
- Lipid metabolism regulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PRAVACHOL | Not yet assigned | — |
Medicinal ingredients
- PRAVASTATIN SODIUM 10 MG per TAB
- PRAVASTATIN SODIUM 20 MG per TAB